Preventing cervical cancer globally by acting locally: if not now, when?
- PMID: 20884892
- PMCID: PMC2957431
- DOI: 10.1093/jnci/djq382
Preventing cervical cancer globally by acting locally: if not now, when?
Figures
Comment in
-
Re: Preventing cervical cancer globally by acting locally: if not now, when?J Natl Cancer Inst. 2011 Apr 6;103(7):611-2; author reply 612-3. doi: 10.1093/jnci/djr049. Epub 2011 Mar 30. J Natl Cancer Inst. 2011. PMID: 21451154 No abstract available.
Comment on
-
Human papillomavirus-based cervical cancer prevention: long-term results of a randomized screening trial.J Natl Cancer Inst. 2010 Oct 20;102(20):1557-67. doi: 10.1093/jnci/djq342. Epub 2010 Sep 30. J Natl Cancer Inst. 2010. PMID: 20884893 Clinical Trial.
References
-
- Farley J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Lyon, France: International Agency for Research on Cancer; 2010. GLOBOCAN 2008: Cancer Incidence and Mortality Worldwide. IARC CaseBase 10.
-
- FUTURE II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med. 2007;356(19):1915–1927. - PubMed
-
- Garland SM, Hernandez-Avila M, Wheeler CM, et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med. 2007;356(19):1928–1943. - PubMed
-
- Paavonen J, Naud P, Salmeron J, et al. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet. 2009;374(9686):301–314. - PubMed
-
- Denny L, Kuhn L, Hu C-C, Tsai W-Y, Wright TC., Jr Human papillomavirus-based cervical cancer prevention: long-term results of a randomized screening trial. J Natl Cancer Inst. 2010;102(20):1557–1567. - PubMed
